Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy
Donor lymphocyte infusion is used to increase the graft versus tumor (GVT) effect after allogeneic hematopoietic cell transplant. The limited spectrum of activity and high risk of graft versus host disease (GVHD) remain major limitations of this approach. The finding of new cell populations for adop...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Poznan University of Medical Sciences
2014-03-01
|
Series: | Journal of Medical Science |
Subjects: | |
Online Access: | https://jms.ump.edu.pl/index.php/JMS/article/view/39 |